| 2D | Two-dimensional |
| 3D | Three-dimensional |
| ARVC | Arrhythmogenic right ventricular cardiomyopathy |
| CF | Cardiac fibroblast |
| CM | Cardiomyocyte |
| DCM | Dilated cardiomyopathy |
| dECM | Decellularized extracellular matrix |
| DVS | Dextran vinyl sulfone |
| ECT | Engineered cardiac tissue |
| EC | Endothelial cell |
| EHT | Engineered heart tissue |
| FFR | Force–frequency relationship |
| HA | Hyaluronic acid |
| HCM | Hypertrophic cardiomyopathy |
| HUVEC | Human umbilical vein endothelial cells |
| hESCs | Human embryonic stem cells |
| hiPSC | Human-induced pluripotent stem cell |
| hPSC | Human pluripotent stem cells |
| -CM | Cardiomyocyte derived from |
| MBCD | Methyl-beta cyclodextrin |
| NHDF | Native human dermal fibroblast |
| PEG | Poly(ethyleneglycol) |
| PDMS | Polydimethylsiloxane |
| PHEMA | Poly(2-hydroxyethyl methacrylate) |
| PVA | Poly(vinyl alcohol) |
| RCM | Restrictive cardiomyopathy |